Co-Diagnostics Inc
NASDAQ:CODX
Co-Diagnostics Inc
NASDAQ:CODX
Price:
2.57
USD
-3.02%
Market Closed
Market Cap:
$5.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Co-Diagnostics Inc
NASDAQ:CODX
|
US |
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
Orchid Island Capital Inc
NYSE:ORC
|
US |
|
Jinhui Liquor Co Ltd
SSE:603919
|
CN |
|
Chart Industries Inc
NYSE:GTLS
|
US |
|
Invictus Energy Ltd
ASX:IVZ
|
AU |
|
CGI Inc
NYSE:GIB
|
CA |
|
W
|
Wedge Holdings Co Ltd
TSE:2388
|
JP |
|
T
|
Tayca Corp
TSE:4027
|
JP |
|
I
|
Investment Friends SE
WSE:IFR
|
EE |
|
Hyundai Pharmaceutical Co Ltd
KRX:004310
|
KR |
Balance Sheet
Balance Sheet Decomposition
Co-Diagnostics Inc
Co-Diagnostics Inc
Balance Sheet Decomposition is not available for
Co-Diagnostics Inc
Co-Diagnostics Inc
Balance Sheet
Co-Diagnostics Inc
Co-Diagnostics Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
4
|
1
|
1
|
43
|
89
|
23
|
15
|
3
|
|
| Cash |
0
|
0
|
1
|
4
|
1
|
1
|
43
|
89
|
23
|
15
|
3
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
1
|
58
|
44
|
27
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
12
|
21
|
5
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
12
|
21
|
4
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
8
|
2
|
5
|
2
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
2
|
1
|
2
|
1
|
|
| Total Current Assets |
0
|
0
|
1
|
5
|
1
|
2
|
68
|
115
|
93
|
62
|
32
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
6
|
5
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
6
|
5
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
27
|
27
|
26
|
26
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+33%
|
1
+225%
|
5
+262%
|
2
-66%
|
2
+38%
|
71
+3 136%
|
160
+125%
|
123
-23%
|
95
-23%
|
64
-33%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
3
|
|
| Accrued Liabilities |
0
|
0
|
1
|
0
|
0
|
0
|
3
|
4
|
1
|
3
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
3
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
8
|
2
|
1
|
1
|
|
| Total Current Liabilities |
0
|
1
|
4
|
0
|
2
|
0
|
4
|
13
|
4
|
6
|
7
|
|
| Long-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
2
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
6
|
2
|
4
|
2
|
|
| Total Liabilities |
0
N/A
|
2
+1 400%
|
4
+187%
|
1
-81%
|
3
+225%
|
1
-81%
|
5
+800%
|
26
+469%
|
9
-66%
|
9
+8%
|
10
+4%
|
|
| Equity | ||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
2
|
4
|
6
|
12
|
19
|
25
|
18
|
54
|
40
|
5
|
33
|
|
| Additional Paid In Capital |
2
|
2
|
3
|
16
|
18
|
27
|
49
|
80
|
89
|
97
|
102
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
14
|
16
|
16
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
1
N/A
|
3
-173%
|
4
N/A
|
1
N/A
|
2
N/A
|
67
+3 824%
|
135
+102%
|
115
-15%
|
86
-25%
|
54
-37%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+33%
|
1
+225%
|
5
+262%
|
2
-66%
|
2
+38%
|
71
+3 136%
|
160
+125%
|
123
-23%
|
95
-23%
|
64
-33%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Switch to:
Switch to:
See Also
Discover More
